Prosecution Insights
Last updated: August 18, 2026

Examiner: HOERNER, PAUL ELLSWORTH

Tech Center 1600 • Art Units: 1611

This examiner grants 50% of resolved cases

Performance Statistics

50.0%
Allow Rate
-10.0% vs TC avg
111
Total Applications
+62.7%
Interview Lift
1328
Avg Prosecution Days
Based on 80 resolved cases, 2023–2026

Rejection Statute Breakdown

1.7%
§101 Eligibility
11.4%
§102 Novelty
48.3%
§103 Obviousness
20.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17751512 SUSPENSION COMPRISING A PROTEIN PARTICLE SUSPENDED IN A NON-AQUEOUS VEHICLE Non-Final OA NOVALIQ GMBH
17286151 MAGNETICALLY RESPONSIVE COMPOSITE MICROPARTICLES FOR TRIGGERED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS Non-Final OA UNIVERSITY OF FLORIDA RESEARCH FOUNDATION
17819268 DRY LIPOSOME FORMULATIONS AND RELATED METHODS THEREOF Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18827288 SPHERICAL AGGLOMERATION OF PROTEINS Non-Final OA Purdue Research Foundation
17600843 LIPID NANOPARTICLES AS ORAL VEHICLES OF IMMUNOTHERAPY Final Rejection The Johns Hopkins University
18715218 Personal Care Compositions Non-Final OA Colgate-Palmolive Company
17434299 MICROWAVE ASSISTED EXTRACTION OF ESSENTIAL OILS FROM PLANT BIOMASS Final Rejection FIRMENICH SA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month